Stoke Therapeutics, Inc.
STOK
$31.27
-$0.04-0.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -61.62M | -50.00M | -57.93M | -38.35M | -23.48M |
| Total Depreciation and Amortization | 458.00K | 439.00K | 405.00K | 442.00K | 446.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.11M | 9.00M | 10.10M | 8.66M | 8.74M |
| Change in Net Operating Assets | -6.54M | -20.01M | 16.98M | -1.12M | -11.12M |
| Cash from Operations | -56.59M | -60.58M | -30.45M | -30.37M | -25.42M |
| Capital Expenditure | -1.98M | -353.00K | -232.00K | -132.00K | -154.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.99M | 51.05M | -60.83M | 9.23M | -148.32M |
| Cash from Investing | 9.02M | 50.69M | -61.06M | 9.09M | -148.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.91M | 84.33M | 92.34M | 3.12M | 554.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.91M | 84.33M | 92.34M | 3.12M | 554.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.66M | 74.44M | 826.00K | -18.15M | -173.35M |